These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 33624948)

  • 41. Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration.
    Horiguchi M; Oiso Y; Sakai H; Motomura T; Yamashita C
    J Control Release; 2015 Sep; 213():112-119. PubMed ID: 26160307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
    Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
    Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration.
    Fu Z; Yin H; Liu J; He Y; Song S; Peng X; Huang X; Lai Y; Li S; Luo Q; Su J; Yang P
    BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37940355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis.
    Gan H; McKenzie R; Hao Q; Idell S; Tang H
    PLoS One; 2014; 9(7):e101983. PubMed ID: 25000413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
    Gharaee-Kermani M; Gyetko MR; Hu B; Phan SH
    Pharm Res; 2007 May; 24(5):819-41. PubMed ID: 17333393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis.
    Todd NW; Atamas SP; Luzina IG; Galvin JR
    Expert Rev Respir Med; 2015 Aug; 9(4):411-8. PubMed ID: 26165208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung.
    Trempus CS; Papas BN; Sifre MI; Bortner CD; Scappini E; Tucker CJ; Xu X; Johnson KL; Deterding LJ; Williams JG; Johnson DJ; Li JL; Sutton D; Ganta C; Mahapatra D; Arif M; Basu A; Pommerolle L; Cinar R; Perl AK; Garantziotis S
    JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37824216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
    Zhang J; Wang D; Wang L; Wang S; Roden AC; Zhao H; Li X; Prakash YS; Matteson EL; Tschumperlin DJ; Vassallo R
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L487-L497. PubMed ID: 30604628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complex urban atmosphere alters alveolar stem cells niche properties and drives lung fibrosis.
    Belgacemi R; Ribeiro Baptista B; Justeau G; Toigo M; Frauenpreis A; Yilmaz R; Der Vartanian A; Cazaunau M; Pangui E; Bergé A; Gratien A; Macias Rodriguez JC; Bellusci S; Derumeaux G; Boczkowski J; Al Alam D; Coll P; Lanone S; Boyer L
    Am J Physiol Lung Cell Mol Physiol; 2023 Oct; 325(4):L447-L459. PubMed ID: 37529852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.
    Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA
    Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
    Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M
    FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial stem cells and niches in lung alveolar regeneration and diseases.
    Zhang J; Liu Y
    Chin Med J Pulm Crit Care Med; 2024 Mar; 2(1):17-26. PubMed ID: 38645714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis.
    Habiel DM; Hohmann MS; Espindola MS; Coelho AL; Jones I; Jones H; Carnibella R; Pinar I; Werdiger F; Hogaboam CM
    BMC Pulm Med; 2019 Aug; 19(1):165. PubMed ID: 31464599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis.
    Cha SI; Groshong SD; Frankel SK; Edelman BL; Cosgrove GP; Terry-Powers JL; Remigio LK; Curran-Everett D; Brown KK; Cool CD; Riches DW
    Am J Respir Cell Mol Biol; 2010 Feb; 42(2):140-8. PubMed ID: 19372246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of MT1-MMP in Alveolar Epithelial Cells Exacerbates Pulmonary Fibrosis.
    Placido L; Romero Y; Maldonado M; Toscano-Marquez F; Ramírez R; Calyeca J; Mora AL; Selman M; Pardo A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic.
    Gazdhar A; Susuri N; Hostettler K; Gugger M; Knudsen L; Roth M; Ochs M; Geiser T
    PLoS One; 2013; 8(6):e65453. PubMed ID: 23840329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Commonalities between the pro-fibrotic mechanisms in COPD and IPF.
    Murray LA
    Pulm Pharmacol Ther; 2012 Aug; 25(4):276-80. PubMed ID: 21983244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alveologenesis: What Governs Secondary Septa Formation.
    Rippa AL; Alpeeva EV; Vasiliev AV; Vorotelyak EA
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis.
    Egea-Zorrilla A; Vera L; Saez B; Pardo-Saganta A
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysregulated cross-talk between alveolar epithelial cells and stromal cells in idiopathic pulmonary fibrosis reduces epithelial regenerative capacity.
    Wisman M; Nizamoglu M; Noordhoek JA; Timens W; Burgess JK; Heijink IH
    Front Med (Lausanne); 2023; 10():1182368. PubMed ID: 37621459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.